First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli from Germany
Valenza G, Werner M, Eisenberger D, Nickel S, Lehner-Reindl V, Hoeller C, Bogdan C (2019)
Publication Type: Journal article
Publication year: 2019
Journal
Book Volume: 17
Pages Range: 305-308
DOI: 10.1016/j.jgar.2019.01.014
Abstract
Objectives: Sequence type 1193 (ST1193) is a new emerging global clone of Escherichia coli. The main goal of this study was to determine the prevalence and molecular characteristics of ST1193 among clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing E. coli from University Hospital of Erlangen, Germany.
Authors with CRIS profile
Markus Werner
Institute of Microbiology – Clinical Microbiology, Immunology and Hygiene
Christian Bogdan
Lehrstuhl für Mikrobiologie und Infektionsimmunologie
Involved external institutions
Germany (DE)How to cite
APA:
Valenza, G., Werner, M., Eisenberger, D., Nickel, S., Lehner-Reindl, V., Hoeller, C., & Bogdan, C. (2019). First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli from Germany. Journal of Global Antimicrobial Resistance, 17, 305-308. https://doi.org/10.1016/j.jgar.2019.01.014
MLA:
Valenza, Giuseppe, et al. "First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli from Germany." Journal of Global Antimicrobial Resistance 17 (2019): 305-308.
BibTeX: Download